Variation in the use of active surveillance for low-risk prostate cancer-Reference-Cited by-同舟云学术

Variation in the use of active surveillance for low-risk prostate cancer

Published:2017-09-13 Issue:1 Volume:124 Page:55-64
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Löppenberg Björn¹²,Friedlander David F.¹,Krasnova Anna¹,Tam Andrew¹,Leow Jeffrey J.³,Nguyen Paul L.⁴,Barry Hawa¹,Lipsitz Stuart R.¹,Menon Mani⁵,Abdollah Firas⁵^ORCID,Sammon Jesse D.⁶^ORCID,Sun Maxine¹,Choueiri Toni K.⁷^ORCID,Kibel Adam S.¹,Trinh Quoc-Dien¹^ORCID

Affiliation:

1. Division of Urological Surgery; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School; Boston Massachusetts

2. Department of Urology; Marien Hospital Herne, Ruhr-University Bochum; Herne Germany

3. Department of Urology; Tan Tock Seng Hospital; Singapore

4. Department of Radiation Oncology; Brigham and Women's Hospital, Harvard Medical School; Boston Massachusetts

5. VUI Center for Outcomes Research, Analytics, and Evaluation, Vattikuti Urology Institute, Henry Ford Health System; Detroit Michigan

6. Division of Urology and Center for Outcomes Research and Evaluation, Maine Medical Center; Portland Maine

7. Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute; Boston Massachusetts

Funder

Heinrich Hertz Foundation of the Ministry of Innovation, Higher Education, and Research of North-Rhine Westphalia (Düsseldorf, Germany)

Vattikuti Urology Institute

Clay Hamlin Young Investigator Award

PCF

Genentech BioOncology Career Development Award

Conquer Cancer Foundation of the American Society of Clinical Oncology

Jerome and Nancy Kohlberg Professorship in Medicine at Harvard Medical School

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer;Klotz;J Clin Oncol.,2010

2. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis;Hayes;JAMA.,2010

3. Prostate cancer, version 1.2016;Mohler;J Natl Compr Canc Netw,2016

4. Trends in management for patients with localized prostate cancer, 1990-2013;Cooperberg;JAMA.,2015

5. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer;Womble;Eur Urol.,2015

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delaying Surgery in Favorable-Risk Prostate Cancer Patients: An NCDB Analysis of Oncologic Outcomes;Clinical Genitourinary Cancer;2024-06

2. Medium‐term follow up of active surveillance for early prostate cancer at a non‐academic institution;BJU International;2024-01-22

3. Association Between Urologist Merit-Based Incentive Payment System Performance and Quality of Prostate Cancer Care;Urology Practice;2024-01

4. Uncovering the Changing Treatment Landscape for Low-risk Prostate Cancer in the USA from 2010 to 2020: Insights from the National Cancer Data Base;European Urology;2023-12

5. Physician Perception of Grade Group 1 Prostate Cancer;European Urology Focus;2023-11